Autus Asset Management, LLC Novo Nordisk A S Transaction History

Autus Asset Management, LLC

$556 Million
Q4 2022

A detailed history of Autus Asset Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Autus Asset Management, LLC holds 7,456 shares of NVO stock, worth $371,159. This represents 0.18% of its overall portfolio holdings.

Number of Shares

7,456

Previous 7,956 6.28%

Holding current value

$371,159

Previous $792,000 27.4%

% of portfolio

0.18%

Previous 0.15%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$102.55 - $135.33 $51,275 - $67,665	-500 Reduced 6.28%	7,456 $0
Q3 2022 Oct 13, 2022	SELL	$95.28 - $116.93 $48,021 - $58,932	-504 Reduced 5.96%	7,956 $792,000
Q2 2022 Jul 22, 2022	SELL	$103.24 - $121.81 $63,182 - $74,547	-612 Reduced 6.75%	8,460 $943,000
Q1 2022 Apr 13, 2022	SELL	$93.1 - $112.54 $2,979 - $3,601	-32 Reduced 0.35%	9,072 $1.01 Million
Q4 2021 Jan 14, 2022	BUY	$95.88 - $117.08 $9,971 - $12,176	104 Added 1.16%	9,104 $1.02 Million
Q3 2021 Oct 18, 2021	SELL	$84.42 - $106.62 $4,221 - $5,331	-50 Reduced 0.55%	9,000 $864,000
Q2 2021 Jul 16, 2021	SELL	$67.66 - $84.76 $2,165 - $2,712	-32 Reduced 0.35%	9,050 $758,000
Q1 2021 Apr 14, 2021	BUY	$67.06 - $75.82 $6,706 - $7,581	100 Added 1.11%	9,082 $612,000
Q4 2020 Jan 19, 2021	SELL	$63.89 - $73.8 $436,368 - $504,054	-6,830 Reduced 43.2%	8,982 $627,000
Q3 2020 Oct 13, 2020	SELL	$63.69 - $70.22 $6,369 - $7,022	-100 Reduced 0.63%	15,812 $1.1 Million
Q2 2020 Jul 16, 2020	SELL	$58.54 - $67.94 $31,787 - $36,891	-543 Reduced 3.3%	15,912 $1.04 Million
Q1 2020 Apr 16, 2020	SELL	$49.46 - $64.78 $59,797 - $78,319	-1,209 Reduced 6.84%	16,455 $991,000
Q4 2019 Jan 24, 2020	SELL	$49.86 - $58.26 $22,187 - $25,925	-445 Reduced 2.46%	17,664 $1.02 Million
Q2 2019 Jul 15, 2019	SELL	$46.79 - $52.47 $1.91 Million - $2.15 Million	-40,914 Reduced 69.32%	18,109 $925,000
Q1 2019 Apr 16, 2019	SELL	$46.36 - $52.63 $3.54 Million - $4.02 Million	-76,312 Reduced 56.39%	59,023 $3.09 Million
Q4 2018 Feb 11, 2019	SELL	$41.54 - $47.25 $752,787 - $856,264	-18,122 Reduced 11.81%	135,335 $6.23 Million
Q3 2018 Oct 26, 2018	SELL	$46.76 - $51.24 $18,142 - $19,881	-388 Reduced 0.25%	153,457 $7.23 Million
Q2 2018 Aug 03, 2018	BUY	$44.29 - $50.42 $92,433 - $105,226	2,087 Added 1.38%	153,845 $7.1 Million
Q1 2018 Apr 24, 2018	SELL	$48.49 - $58.14 $86,700 - $103,954	-1,788 Reduced 1.16%	151,758 $7.47 Million
Q4 2017 Feb 01, 2018	SELL	$47.53 - $53.73 $111,220 - $125,728	-2,340 Reduced 1.5%	153,546 $8.24 Million
Q3 2017 Nov 08, 2017	SELL	$41.15 - $49.22 $65,469 - $78,309	-1,591 Reduced 1.01%	155,886 $7.51 Million
Q2 2017 Aug 09, 2017	BUY	N/A	157,477	157,477 $6.75 Million

Others Institutions Holding NVO

# of Institutions

1,744

Shares Held

337M

Call Options Held

10.7M

Put Options Held

16M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $112B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Autus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Autus Asset Management, LLC with notifications on news.

Account

Autus Asset Management, LLC Novo Nordisk A S Transaction History